New delayed-release stimulant improves morning ADHD symptoms and all-day functioning

(Mary Ann Liebert, Inc./Genetic Engineering News) A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news